[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

African Trypanosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 40 pages | ID: A2C8B026353FEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
African Trypanosomiasis Drug pipeline report- 2020 is an annual R&D review of African Trypanosomiasis pipeline candidates. The report presents the current status of all major African Trypanosomiasis therapeutic compounds. Detailed insights into African Trypanosomiasis pipeline development, current status, companies, drug profiles and African Trypanosomiasis preclinical and clinical trials are included.

2020 African Trypanosomiasis Pipeline Market Insights
African Trypanosomiasis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of African Trypanosomiasis therapies, pipeline by phase and others are included.

African Trypanosomiasis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

African Trypanosomiasis Therapeutic Drug candidates
Both active and inactive African Trypanosomiasis pipeline drug candidates are included in the report

African Trypanosomiasis Clinical Trials and preclinical Studies
African Trypanosomiasis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

African Trypanosomiasis pipeline market developments
African Trypanosomiasis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

African Trypanosomiasis pipeline companies in active development
The report analyzes African Trypanosomiasis pipeline of the below companies-

F. Hoffmann-La Roche Ltd, Incuron LLC, MediSynergics LLC, Novartis AG, Sanofi, Scynexis Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
6 Companies investing in African Trypanosomiasis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each African Trypanosomiasis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. AFRICAN TRYPANOSOMIASIS PIPELINE MARKET INSIGHTS, 2020

1.1 African Trypanosomiasis Disease Overview
1.2 African Trypanosomiasis Drug Pipeline Snapshot, 2020
  1.2.1 African Trypanosomiasis Pipeline Drugs by Phase
  1.2.2 African Trypanosomiasis Pipeline Drugs by Company
  1.2.3 African Trypanosomiasis Pipeline Drugs by Mechanism of Action
  1.2.4 African Trypanosomiasis Pipeline Drugs by Route of Administration

2. AFRICAN TRYPANOSOMIASIS COMPANY WISE PIPELINE DETAILS

F. Hoffmann-La Roche Ltd African Trypanosomiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Incuron LLC African Trypanosomiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
MediSynergics LLC African Trypanosomiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novartis AG African Trypanosomiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi African Trypanosomiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Scynexis Inc African Trypanosomiasis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. AFRICAN TRYPANOSOMIASIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. AFRICAN TRYPANOSOMIASIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications